spondylitis, ankylosing

Recapture and retreatment rates with ixekizumab after withdrawal of therapy in patients with axial spondyloarthritis: results at week 104 from a randomised placebo-controlled withdrawal study
Robert B M Landewé, Denis Poddubnyy, Proton Rahman, Filip E Van den Bosch, Rebecca Bolce, Soyi Liu Leage, Jeffrey R Lisse, So Young Park, Lianne Gensler

Annals of the Rheumatic Diseases Sep 2022, annrheumdis-2022-222731; DOI: 10.1136/ard-2022-222731
Treat-to-target dose reduction and withdrawal strategy of TNF inhibitors in psoriatic arthritis and axial spondyloarthritis: a randomised controlled non-inferiority trial
Celia AJ Michielsens, Nathan den Broeder, Frank HJ van den Hoogen, Elien AM Mahler, Steven Teerenstra, Désirée van der Heijde, Lise M Verhoef, Alfons A den Broeder

Annals of the Rheumatic Diseases Oct 2022, 81 (10) 1392-1399; DOI: 10.1136/annrheumdis-2022-222260
Pregnancy and neonatal outcomes in women with axial spondyloarthritis: pooled data analysis from the European Network of Pregnancy Registries in Rheumatology (EuNeP)
Yvette Meissner, Anja Strangfeld, Anna Molto, Frauke Forger, Marianne Wallenius, Nathalie Costedoat-Chalumeau, Hilde Bjørngaard, Marion Couderc, René-Marc Flipo, Gaëlle Guettrot-Imbert, Isabell Haase, Bente Jakobsen, Hege Suorza Svean Koksvik, Christophe Richez, Jérémie Sellam, Anja Weiß, Astrid Zbinden, Rebecca Fischer-Betz

Annals of the Rheumatic Diseases Aug 2022, annrheumdis-2022-222641; DOI: 10.1136/ard-2022-222641
Diagnostic evaluation of the sacroiliac joints for axial spondyloarthritis: should MRI replace radiography?
Denis Poddubnyy, Torsten Diekhoff, Xenofon Baraliakos, Kay Geert A Hermann, Joachim Sieper

Annals of the Rheumatic Diseases Aug 2022, ard-2022-222986; DOI: 10.1136/ard-2022-222986
MRI lesions of the spine in patients with axial spondyloarthritis: an update of lesion definitions and validation by the ASAS MRI working group
Xenofon Baraliakos, Mikkel Østergaard, Robert GW Lambert, Iris Eshed, Pedro M Machado, Susanne Juhl Pedersen, Ulrich Weber, Manouk de Hooge, Joachim Sieper, Denis Poddubnyy, Martin Rudwaleit, Désirée van der Heijde, Robert BM Landewé, Walter P Maksymowych

Annals of the Rheumatic Diseases Sep 2022, 81 (9) 1243-1251; DOI: 10.1136/annrheumdis-2021-222081
Treatment with tumour necrosis factor inhibitors is associated with a time-shifted retardation of radiographic spinal progression in patients with axial spondyloarthritis
Murat Torgutalp, Valeria Rios Rodriguez, Ani Dilbaryan, Fabian Proft, Mikhail Protopopov, Maryna Verba, Judith Rademacher, Hildrun Haibel, Joachim Sieper, Martin Rudwaleit, Denis Poddubnyy

Annals of the Rheumatic Diseases Sep 2022, 81 (9) 1252-1259; DOI: 10.1136/annrheumdis-2022-222324
Efficacy and safety of upadacitinib for active ankylosing spondylitis refractory to biological therapy: a double-blind, randomised, placebo-controlled phase 3 trial
Désirée van der Heijde, Xenofon Baraliakos, Joachim Sieper, Atul Deodhar, Robert D Inman, Hideto Kameda, Xiaofeng Zeng, Yunxia Sui, Xianwei Bu, Aileen L Pangan, Peter Wung, In-Ho Song

Annals of the Rheumatic Diseases Jul 2022, annrheumdis-2022-222608; DOI: 10.1136/ard-2022-222608
Response to: ‘Beware of wolves in sheep's clothing: immune cell plasticity and instability in health and disease’ by Alunno et al
Abdulla Watad, Hannah Rowe, Darren Newton, Charlie Bridgewood, Dennis G McGonagle

Annals of the Rheumatic Diseases Jul 2022, 81 (7) e130; DOI: 10.1136/annrheumdis-2020-218151
Instrument selection for the ASAS core outcome set for axial spondyloarthritis
Victoria Navarro-Compán, Anne Boel, Annelies Boonen, Philip J Mease, Maxime Dougados, Uta Kiltz, Robert B M Landewé, Xenofon Baraliakos, Wilson Bautista-Molano, Praveena Chiowchanwisawakit, Hanne Dagfinrud, Lara Fallon, Marco Garrido-Cumbrera, Lianne Gensler, Bassel Kamal ElZorkany, Nigil Haroon, Yu Heng Kwan, Pedro M Machado, Walter Maksymowych, Anna Molto, Natasha de Peyrecave, Denis Poddubnyy, Mikhail Protopopov, Sofia Ramiro, In-Ho Song, Salima van Weely, Désirée van der Heijde

Annals of the Rheumatic Diseases Jun 2022, annrheumdis-2022-222747; DOI: 10.1136/annrheumdis-2022-222747
EULAR points to consider for therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal diseases
Charlotte LM Krieckaert, Astrid van Tubergen, Johanna Elin Gehin, Borja Hernández-Breijo, Guillaume Le Mélédo, Alejandro Balsa, Peter Böhm, Sasa Cucnik, Ori Elkayam, Guro L Goll, Femke Hooijberg, Meghna Jani, Patrick DW Kiely, Neil McCarthy, Denis Mulleman, Victoria Navarro-Compán, Katherine Payne, Martin E Perry, Chamaida Plasencia-Rodriguez, Simon R Stones, Silje Watterdal Syversen, Annick de Vries, Katherine M Ward, Gertjan Wolbink, John D Isaacs

Annals of the Rheumatic Diseases May 2022, annrheumdis-2022-222155; DOI: 10.1136/annrheumdis-2022-222155

Main menu

spondylitis, ankylosing

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

spondylitis, ankylosing

Pages